Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2

Melatonin was shown to prevent or mitigate a number of different respiratory and non-respiratory viral diseases. Given its non-specific anti-viral action, it is likely to be effective against the delta variant of SARS-CoV-2 as well as any eventual future variants of the virus.